David Coy from Chicago, IL, age 37

License Records

David Lawrence Coy

License #:

0225202963

Category:

Real Estate Individual

Us Patents

Glp-1 Analogues
view source
US Patent:

7368427, May 6, 2008
Filed:

Dec 7, 1999
Appl. No.:

09/856676
Inventors:

Zheng Xin Dong - Holliston MA, US
David H. Coy - New Orleans LA, US
Assignee:

Societe de Conseils de Recherches et d'Applications Scientifiques, SAS - Paris
The Administrators of the Tulane Educational Fund - New Orleans LA
International Classification:

A61K 38/26
C07K 14/605
US Classification:

514 12, 530324, 530308
Abstract:

The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefor comprising said analogues.

Method Of Modulating The Proliferation Of Medullary Thyroid Carcinoma Cells
view source
US Patent:

20070259811, Nov 8, 2007
Filed:

May 2, 2007
Appl. No.:

11/799594
Inventors:

Ettore Degli Uberti - Ferrara, IT
Maria Zatelli - Ferrara, IT
Michael Culler - Hopkinton MA, US
David Coy - New Orleans LA, US
International Classification:

A61K 38/12
A61P 35/00
C12N 5/02
US Classification:

514009000, 435375000
Abstract:

The present invention is directed to a method of decreasing the rate of proliferation of medullary thyroid carcinoma cells which comprises contacting medullary thyroid carcinoma cells with one or more SSTR2 agonist. A somatostatin receptor antagonist having the formula Cpa-cyclo(D-Cys-4-Pal-D-Trp-Lys-Thr-Cys)-Nal-NHis also disclosed.

Glp-1 Analogues
view source
US Patent:

20090149378, Jun 11, 2009
Filed:

May 6, 2008
Appl. No.:

12/115976
Inventors:

Zheng Xin Dong - Holliston MA, US
David H. Coy - New Orleans LA, US
Assignee:

Biomeasure, Incorporated - Milford MA
The Administrators of the Tulane Educational Fund - New Orleans LA
International Classification:

A61K 38/26
C07K 14/605
A61P 3/00
A61P 3/04
A61P 19/00
A61P 25/00
A61P 3/10
US Classification:

514 12, 530324
Abstract:

The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefor comprising said analogues.

Method Of Modulating The Proliferation Of Medullary Thyroid Carcinoma Cells
view source
US Patent:

20110183416, Jul 28, 2011
Filed:

Jun 5, 2007
Appl. No.:

11/810268
Inventors:

Ettore Ciro Degli Uberti - Ferrara, IT
Maria Chiara Zatelli - Ferrara, IT
Michael Dewitt Culler - Hopkinton MA, US
David H. Coy - New Orleans LA, US
International Classification:

C12N 5/09
C07K 7/00
US Classification:

435375, 530318
Abstract:

The present invention is directed to a method of decreasing the rate of proliferation of medullary thyroid carcinoma cells which comprises contacting medullary thyroid carcinoma cells with one or more SSTR2 agonist. A preferred selective somatostatin receptor type-2 (SSTR-2) agonist cyclo[Tic-Tyr-D-Trp-Lys-Abu-Phe] is also disclosed.

Name / Title

Company / Classification

Phones & Addresses

David Coy
Soc signatory

NORDEN BROTHERS ROOFING & SHEET METAL, LLC

30 Pleasant St, Wakefield, MA 01880
East Weymouth, MA 02189

Medicine Doctors

David A. Coy

view source

Specialties:

Obstetrics & Gynecology

Work:

First Desert Obstetrics & Gynecology
81767 Doctor Carreon Blvd STE 101, Indio, CA 92201
760-342-5268 (phone), 760-347-0088 (fax)

Education:

Medical School
Northeastern Ohio Universities College of Medicine
Graduated: 1995

Procedures:

Ovarian Surgery
Cesarean Section (C-Section)
Hysterectomy
Tubal Surgery
Vaginal Delivery

Conditions:

Genital HPV
Menopausal and Postmenopausal Disorders
Pregnancy-Induced Hypertension
Uterine Leiomyoma
Abnormal Vaginal Bleeding

Languages:

English
Spanish

Description:

Dr. Coy graduated from the Northeastern Ohio Universities College of Medicine in 1995. He works in Indio, CA and specializes in Obstetrics & Gynecology. Dr. Coy is affiliated with John F Kennedy Memorial Hospital.